Onlykashmir.in News Desk
The central government has moved to close a longstanding regulatory gap by withdrawing the exemption that had previously allowed cough syrups to be sold in small rural villages without the standard licensing requirements applicable to other drugs, in a move that brings their distribution firmly within the oversight of the formal pharmaceutical regulatory framework.
The Ministry of Health and Family Welfare has notified an amendment to the Drugs Rules, 1945, through a gazette notification. The amendment removes the word “Syrup” from Schedule K of the Drugs Rules under the heading “Class of Drugs.” Schedule K had historically exempted certain categories of drugs from specific provisions of the Drugs and Cosmetics Act, 1940, enabling their sale in villages with a population of less than one thousand without requiring compliance with retail sale licensing conditions.
With the removal of “Syrup” from Schedule K, cough syrups no longer qualify for this exemption. Going forward, the sale and dispensing of cough syrups anywhere in India, including in the smallest and most remote villages, will be permissible only through pharmacies holding a valid drug retail licence issued under the Drugs and Cosmetics Act, 1940, and the rules framed under it.
The Ministry has stated that the amendment is intended to strengthen regulatory oversight of syrup formulations and to align the exemption framework with contemporary public health and safety requirements. Cough syrups have attracted particular regulatory attention in India over the past several years, following a series of international incidents in which substandard Indian-manufactured syrup products were linked to fatalities, primarily among children, in several countries. Domestically, some cough syrup formulations containing codeine and other scheduled substances have been widely misused as a low-cost intoxicant, raising serious public health concerns.
The requirement that cough syrups be dispensed only by licensed pharmacies is expected to make it significantly harder for adulterated, substandard, or non-compliant products to reach consumers through informal village-level channels. It also creates an additional layer of accountability in the supply chain, as licensed pharmacies are subject to periodic inspection and regulatory scrutiny that unlicensed outlets are not.
